Why Longevity Science Is a Good Bet

​Join us for an engaging talk with Michael Ringel, JD, PhD, former Managing Director and Senior Partner at Boston Consulting Group. After 25 years at BCG leading innovation and strategy across industries, Michael has taken a bold step into the future—joining Life Biosciences as Chief Operating Officer. In this session, he’ll share why he believes longevity science is one of the most promising frontiers in biotech today, what drew him to this mission-driven field, and how breakthroughs in aging research are poised to reshape healthcare, investment, and human potential.

​Whether you're curious about the science of aging, exploring career pivots, or tracking biotech trends, this is a unique chance to hear directly from a leader at the forefront of the longevity revolution.